A latest study has found that the women who already have been treated for early-stage breast cancer are more likely to fret about the recurrence of the disease.

Researchers believe that the type of anxiety involved with worrying about it might compromise the medical care and quality of life of a woman.

Study author Nancy Janz, of the University of Michigan School of Public Health, believes that several women worry about recurrence is often not aligned with their actual risk for cancer recurrence.

In addition, she added, “For most women diagnosed with early-stage breast cancer, the risk for recurrence is low. Nonetheless, many worry a lot, and we need to better understand the factors that increase the likelihood that women will worry and develop strategies and appropriate referrals to help women with excessive worry”.

To reach on these conclusions, researchers included 2,290 women diagnosed with non-metastatic breast cancer and after analyzing all the collected data, they found that the women who were able to understand clinical information presented to them were least likely to worry about the cancer recurrence.

The study also highlighted many factors like being younger, having a job, experiencing more pain and fatigue and undergoing radiation treatment behind this phenomenon.